Advanced Wound Care Market Set To Grow To Over $14.9bn In 2017

10 August 2017
Pharma

Visiongain has launched a new pharma report Advanced Wound Care Market Forecast 2017-2027: Revenue Prospects for Active Wound Care Dressings (Antimicrobial, Foam, Hydrocolloid, Film, Alginate, Hydrogel, Other) Wound Care Devices (NPWT, Ultrasound, Other) and Wound Care Biologics (Skin Replacement, Collagen-Based, Cell-Based, Other) and Geography

The skin covers an area of approximately two square metres. Among many functions the skin performs, one of its roles is an organ of protection from mechanical impacts and pressure, and micro-organisms. Skin is the outer covering of the body, and is a vital organ in the body’s defence against external harm as well as playing a vital role in facilitating tasks such as maintaining the body’s fluid balance and providing temperature regulation and immune function. The skin performs numerous physiological tasks, which explains the need for its complicated structure. The skin protects the body against pressure friction, heat and cold, ultraviolet radiation, chemicals and infections.

Skin wounds by true definition is a breakdown in the protective function of the skin, the loss of continuity of epithelium, with or without loss of underlying connective tissue following injury to the skin or underlying tissues/organs caused by surgery, a blow, a cut, chemicals, heat/cold, friction/shear force, pressure or as a result of disease such as a leg ulcer or carcinomas. Wounds may vary considerably according to their cause and severity; a wound may be described in many ways, by its: aetiology, anatomical location, whether it is acute or chronic, the method of closure, presenting symptoms, the predominant tissue type in the wound bed.

The lead Visiongain report analyst for this report commented; “Wound healing is the process by which skin or other body tissue repairs itself after trauma. When a wound occurs the skin barrier is broken, and an orchestrated cascade of biochemical events is set into motion to repair the damage. In some cases, the mechanisms governing wound repair may be altered or suspended, leading to slow healing or even the non-healing of wounds.
Wounds generally heal quickly in younger patients. As the skin ages, the epidermis becomes thinner and flatter, there is a decrease in the number of melanocytes (pigment producing cells), blood supply to the dermis reduces, there are less elastic fibres, the amount of collagen is reduced, and the rate of protein turnover also is reduced.
Certain diseases are also noted for causing poor wound healing. The most common of these problematic diseases is diabetes mellitus. Scars formed by diabetics have less collagen; the collagen that is synthesised is more brittle than normal. Diabetes also damages blood vessels and makes the skin more prone to ischemia. The reduced circulation is especially notable in the feet and foot wounds are notorious for not healing well in diabetic patients.
The global population of people aged over 65 is projected to increase from 610 million people in 2015 (8% of the global population) to 1.2 billion in 2035 (16% of the global population). Increased age is correlated with an increased propensity to develop chronic wounds, thus resulting in an increased demand for wound care products. In addition, there is an increased incidence of obesity and diabetes in the global population, with the World Health Organisation (WHO) projecting these numbers continuing to increase. The number of people with diabetes is expected to rise from 415 million in 2015 to 642 million by 2040. Higher incidences of diabetes and obesity and associated conditions are contributing factors to an increasing incidence of chronic wounds”.
The Advanced Wound Care market is highly competitive with many different players entering the market. The report discusses selected leading companies in the market. Notable companies in the Advanced Wound Care market include Smith & Nephew, Acelity, Mölnlycke, ConvaTec, Coloplast and Organogenesis

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Influenza Vaccines Market Report 2020-2030

For the companies operating in the global influenza vaccines market, there is an immense opportunity from emerging economies across the globe.

30 September 2020

Read

Visiongain Publishes Next-Generation Pharmaceutical Temperature Management Solutions Market Report 2020-2030

Maintaining the quality and safety of the product in the supply chain has always been a high priority for pharmaceutical companies. New market dynamics including an evolving product line, more stringent regulations, geographically connected supply chains, rising risk, and extreme cost pressure have raised stakes significantly.

28 September 2020

Read

Visiongain Publishes OTC Drugs & Dietary Supplements Market Report 2020-2030

The increasing rates of patent expiry lead to a counter-strategy of switching companies from Rx to OTC. In the US, according to the Consumer Healthcare Products Association, approximately 106 ingredients and dosage strengths have undergone a change from Rx to OTC to around 700 OTC products on the market.

23 September 2020

Read

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever